|
Issue |
Title |
|
Vol 10, No 3 (2022) |
Approaches to Assessing the Safety of Medicines during the COVID-19 Pandemic Using the Example of Azithromycin |
Abstract
PDF (Rus)
|
Yu. M. Gomon, A. R. Kasimova, A. S. Kolbin, V. V. Strizheletsky, I. G. Ivanov, S. O. Mazurenko |
|
Vol 10, No 3 (2022) |
Evaluation of the Rationality of Antibiotic Therapy of Nosocomial Infections in Resuscitation and Intensive Care Patients with COVID-19: a Retrospective Analysis |
Abstract
PDF (Rus)
|
K. I. Karnoukh, N. B. Lazareva |
|
Vol 10, No 1 (2022) |
Ivermectin: Evaluation of Efficacy and Safety in COVID-19 |
Abstract
PDF (Rus)
|
E. V. Shubnikova, N. A. Susekova, T. M. Bukatina, M. S. Galenko, A. A. Druzhinina |
|
Vol 10, No 1 (2022) |
Safety of Therapy with Tocilizumab and Other Interleukin Inhibitors |
Abstract
PDF (Rus)
|
V. I. Petrov, A. Y. Ryazanova, D. A. Nekrasov, V. I. Svinukhov, N. S. Privaltseva |
|
1 - 4 of 4 Items |
|